About QAWaCh Bio
QAWaCh Bio is a Healthcare company based in Navi Mumbai (India) founded in 2018 by Kunal and Mohan Singh. QAWaCh Bio has raised $7.21 thousand across 1 funding round. Its Indian entity Qawach Bio Private Limited reported revenue of ₹4.3 Lakh. QAWaCh Bio offers products and services including InstaNGAL®, InstaCOVID Ag, Uncut Sheets & Reagents, and Product Development Services. Its focus areas include Life Sciences, Infectious Diseases, In Vitro Diagnostic Tests and Viral.
Company details
Developer of rapid diagnostic test kits for the detection kidney and infectious diseases. The companys products include InstaNGAL is a quantitative bedside test kit that is intended for early diagnosis of acute kidney injury and InstaCOVID Ag is a qualitative rapid antigen test kit for COVID-19 detection.
- Headquarters Navi Mumbai, India
- Founders Kunal, Mohan Singh
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website qawachbio.com
- Social LinkedIn Facebook Instagram
- Legal Name Qawach Bio Private Limited
- Date of Incorporation 24 May, 2018
- Jurisdiction Navi Mumbai, Maharashtra, India
- Annual Revenue₹4.3 Lakh
FY 2025 · -43% YoY
- Net Loss-₹5.2 Lakh
FY 2025 · -122% margin
- EBITDA-₹4.4 Lakh
FY 2025 · -103% margin
- Total Equity Funding$7.21K (USD)
in 1 rounds
- Latest Funding Round$7.21K (USD), Angel Round
Jun 2019
Associated legal entities of QAWaCh Bio
QAWaCh Bio operates through Qawach Bio Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Qawach Bio Private Limited CIN U33208MH2018PTC309912 | Active | 24 May 2018 | Navi Mumbai, Maharashtra | ₹0.0 Cr | 2 | View details |
Products & Services of QAWaCh Bio
QAWaCh Bio offers a comprehensive portfolio of products and services, including InstaNGAL®, InstaCOVID Ag, Uncut Sheets & Reagents, and Product Development Services.
Quantitative test kit for early biomarker detection in healthcare.
Rapid antigen test for detecting COVID-19 infections.
Materials to enhance sensitivity in rapid test kits.
Assistance in developing and improving IVD-based products.
Funding Insights of QAWaCh Bio
QAWaCh Bio has successfully raised a total of $7.21K through 1 strategic funding round. The most recent funding activity was a Angel Round of $7.21 thousand completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7,210
- Total Rounds 1
- Last Round Angel Round — $7,210
- First Round $7,210
(Jun 2019)
All 1 funding rounds of QAWaCh Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2019 | $7,210 | Angel Round | – | – | – |
Board of directors of Qawach Bio Private Limited (QAWaCh Bio)
Qawach Bio Private Limited is the primary company behind QAWaCh Bio. The board of Qawach Bio Private Limited currently have 2 directors; the longest-serving is Rashmi Tambe Shukla, appointed in 2018. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rashmi Tambe Shukla DIN 08142379 | Director | 24 May 2018 | 8 yrs 5 mo | Qawach Bio Private Limited |
| Mohan Singh DIN 08142380 | Director | 24 May 2018 | 8 yrs 5 mo | Qawach Bio Private Limited |
People of QAWaCh Bio
3 people are tracked at QAWaCh Bio (3 in leadership).
| Name | Role | Group |
|---|---|---|
Kunal | Co-Founder | Leadership |
| Co-Founder & Director | Leadership | |
| Managing Director | Leadership |
Complete people profiles for QAWaCh Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of QAWaCh Bio
Figures of Qawach Bio Private Limited, the primary company behind QAWaCh Bio, for FY 2025. Revenue was ₹4.3 Lakh (-43% year on year). Net loss was -₹5.2 Lakh (-122% margin). EBITDA was -₹4.4 Lakh (-103% margin). Revenue has grown at a compounded annual rate of -42% over three years and -6% over five years.
- ₹4.3 LakhRevenue · FY 2025 · -43% YoY
- -₹5.2 LakhNet loss · -122% margin
- -₹4.4 LakhEBITDA · -103% margin
- ₹21 LakhPaid-up capital
- -42%Revenue CAGR, 3 years
- -6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Qawach Bio Private Limited are on its company page.
Detailed financial statements for QAWaCh Bio
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of QAWaCh Bio
2 dated milestones of QAWaCh Bio across 1 years, from founding to its latest funding, stage changes and deals.
- Founded QAWaCh Bio is founded.
- Funding First funding round of $7K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about QAWaCh Bio
QAWaCh Bio was founded in 2018 and raised its 1st funding round 1 year after it was founded.
QAWaCh Bio is headquartered in Navi Mumbai, India. It is registered at Navi Mumbai, Maharashtra, India.
QAWaCh Bio is a funded company, having raised a total of $7.21K across 1 funding round to date. The company's 1st funding round was a Angel Round of $7.21K, raised on Jun 2019.
The primary company behind QAWaCh Bio, Qawach Bio Private Limited, reported revenue of ₹4.3 Lakh for FY 2025, down 43% year on year.
Developer of rapid diagnostic test kits for the detection kidney and infectious diseases. The companys products include InstaNGAL is a quantitative bedside test kit that is intended for early diagnosis of acute kidney injury and InstaCOVID Ag is a qualitative rapid antigen test kit for COVID-19 detection.
QAWaCh Bio offers InstaNGAL®, InstaCOVID Ag, Uncut Sheets & Reagents, and Product Development Services.
QAWaCh Bio operates through Qawach Bio Private Limited.
The legal entities of QAWaCh Bio currently have 2 directors, including Rashmi Tambe Shukla, Mohan Singh.